³Ô¹ÏÍøÕ¾

Latest antiviral News | Page 5

SARS-CoV-2 virus can infect heart’s pacemaker cells
First Participants dosed in ENA Respiratory’s phase 2a study
Targeting viral lung infections two ways
Elevated inflammation persists in immune cells months after mild Covid
WHO updates its treatment guidelines to include molnupiravir
First Covid pill funded through PBS
Existing drug may protect against COVID lung injury
PFIZER: TGA Approves Pfizer’s Novel Covid Oral Treatment in Australia
Covid pill LAGEVRIO approved for use in Australia
NZ secures new Pfizer Covid medicine
South-East Asia: Influenza virus sharing in time of Covid
Expert panel confirms “quality of life” as key focus for Australians living with HIV
Biotron’s BIT225 effective against Covid in animal study
Gates Foundation funding for University to develop low cost manufacturing route to promising Covid therapy Molnupiravir
WHO-Unitaid statement on MPP licensing agreement for molnupiravir
TGA grants provisional determination to Pfizer Australia’s Covid treatment PF-07321332 + ritonavir
Australia secures access to additional Covid treatment
Government must buy Covid treatments now
Liquid Metal Coating Creates Effective Antiviral, Antimicrobial Fabric
10 minute testing device could reduce spread of COVID19 in hospitals
Unusual blue woodlice may help develop new antiviral materials